Filing Details
- Accession Number:
- 0001209191-23-005036
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-26 16:05:48
- Reporting Period:
- 2023-01-24
- Accepted Time:
- 2023-01-26 16:05:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1438533 | Travere Therapeutics Inc. | TVTX | Pharmaceutical Preparations (2834) | 262383102 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1698262 | E. William Rote | C/O Travere Therapeutics, Inc. 3611 Valley Centre Drive, Ste 300 San Diego CA 92130 | Senior Vice President, R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-01-24 | 2,062 | $21.50 | 42,376 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.
- Includes 354 shares of the Issuer's common stock acquired by the reporting person on May 31, 2022 pursuant to an employee stock purchase program and 412 shares of the Issuer's common stock acquired by the reporting person on November 30, 2022 pursuant to an employee stock purchase program.
Billionaire Hedge Funds
